Role of G protein‐coupled receptor kinases (GRKs) in β2‐adrenoceptor‐mediated glucose uptake

Seungmin Ham,Saori Mukaida,Masaaki Sato,Peter Keov,Tore Bengtsson,Sebastian Furness,Nicholas D. Holliday,Bronwyn A. Evans,Roger J. Summers,Dana S. Hutchinson

DOI: https://doi.org/10.1002/prp2.1176

2024-02-10

Pharmacology Research & Perspectives

Abstract:Abstract Truncation of the C‐terminal tail of the β 2 ‐AR, transfection of βARKct or over‐expression of a kinase‐dead GRK mutant reduces isoprenaline‐stimulated glucose uptake, indicating that GRK is important for this response. We explored whether phosphorylation of the β 2 ‐AR by GRK2 has a role in glucose uptake or if this response is related to the role of GRK2 as a scaffolding protein. CHO‐GLUT4myc cells expressing wild‐type and mutant β 2 ‐ARs were generated and receptor affinity for [ 3 H]‐CGP12177A and density of binding sites determined together with the affinity of isoprenaline and BRL37344. Following receptor activation by β 2 ‐AR agonists, cAMP accumulation, GLUT4 translocation, [ 3 H]‐2‐deoxyglucose uptake, and β 2 ‐AR internalization were measured. Bioluminescence resonance energy transfer was used to investigate interactions between β 2 ‐AR and β‐arrestin2 or between β 2 ‐AR and GRK2. Glucose uptake after siRNA knockdown or GRK inhibitors was measured in response to β 2 ‐AR agonists. BRL37344 was a poor partial agonist for cAMP generation but displayed similar potency and efficacy to isoprenaline for glucose uptake and GLUT4 translocation. These responses to β 2 ‐AR agonists occurred in CHO‐GLUT4myc cells expressing β 2 ‐ARs lacking GRK or GRK/PKA phosphorylation sites as well as in cells expressing the wild‐type β 2 ‐AR. However, β 2 ‐ARs lacking phosphorylation sites failed to recruit β‐arrestin2 and did not internalize. GRK2 knock‐down or GRK2 inhibitors decreased isoprenaline‐stimulated glucose uptake in rat L6 skeletal muscle cells. Thus, GRK phosphorylation of the β 2 ‐AR is not associated with isoprenaline‐ or BRL37344‐stimulated glucose uptake. However, GRKs acting as scaffold proteins are important for glucose uptake as GRK2 knock‐down or GRK2 inhibition reduces isoprenaline‐stimulated glucose uptake.

pharmacology & pharmacy